Hepatitis C - The case against treatment

European Journal of Surgery, Supplement

Volumn 167, Issue 586, 2001, Pages 34-39

  Koretz, R L ^a  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; RIBAVIRIN; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE COURSE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FLU LIKE SYNDROME; HEPATITIS C; HUMAN; LIFE EXPECTANCY; LIVER BIOPSY; LIVER FAILURE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; VIRUS LOAD; REVIEW;

HEPATITIS C, CHRONIC; HUMANS; INTERFERONS;

EID: 0034740542     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Deaths and hospitalizations from chronic liver disease and cirrhosis - United States, 1980-1989
2. Estimates of the cost-effectiveness of a single course of interferon α-2b in patients with histologically mild chronic hepatitis C
3. Treatment of chronic hepatitis C with recombinant interferon alfa
4. Quality forum on hepatitis C virus
5. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C
6. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
7. Cost-effectiveness of 6 and 12 months of interferon-α therapy for chronic hepatitis C
8. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C
9. Non-A, non-B post-transfusion hepatitis at the quarter century
10. Non-A, non-B post-transfusion hepatitis
11. Acute hepatitis: Science and superstition
12. Chronic hepatitis: More quotes and misquotes
13. Interferon and hepatocellular carcinoma
14. 10-year follow-up after interferon-α therapy for chronic hepatitis C
15. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
16. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy
17. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
18. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study
19. Randomised trial of effects of interferon-α on incidence of cellular carcinoma in chronic active hepatitis C with hepatocirrhosis
20. National Institutes of Health consensus development conference panel statement: Management of hepatitis C
21. Randomised trial of interferon 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
22. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C
23. Long-term mortality after transfusion-associated non-A, non-B hepatitis
24. 45-50 Year follow-up of hepatitis C virus (HCV) infection among young military recruits
25. Interferon and hepatitis C
26. Clinical outcomes after transfusion-associated hepatitis
27. Pretreatment evaluation of chronic hepatitis C
28. Cost-effectiveness of interferon-α 2b treatment for hepatitis B e antigen-positive chronic hepatitis B
29. Updated long-term mortality of transfusion-associated hepatitis (TAH), non-A, non-B and C